SCHEMBL10124124

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL19821391	0.89	DGKA (0.44)	DGKAADRA2AADRA1ADNM1MAPT
	SCHEMBL6105192	0.88	DGKA (0.52)	DGKADNM1MAPTL3MBTL1HTR2C
	SCHEMBL6420417	0.87	DGKA (0.41)	DGKAADRA2AADRA1AMAPTBLM
	SCHEMBL28162481	0.85	DGKA (0.58)	DGKADNM1MAPTL3MBTL1CNR1
	SCHEMBL10009581	0.85	MEN1 (0.42)	DGKAADRA2AADRA1AMAPTBLM
	SCHEMBL576951	0.83	DGKA (0.45)	DGKAADRA2AADRA1ADNM1MAPT
	SCHEMBL9183515	0.83	DGKA (0.48)	DGKAADRA2AADRA1ADNM1MAPT
	SCHEMBL101402	0.83	—	—
	SCHEMBL28162482	0.82	NAAA (0.48)	DGKADNM1MAPTBLMNAAA
	SCHEMBL10011102	0.82	L3MBTL1 (0.50)	DGKAADRA2AADRA1ADNM1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.